Hope on the horizon: how pegbelfermin offers a glimmer of hope for NASH sufferers?
Madam, Non-alcoholic steatohepatitis (NASH), is described as having hepatic steatosis of >5%, inflammation, and hepatocyte damage (such as ballooning), including or excluding fibrosis¹. NASH falls under a group of liver diseases termed Non-alcoholic Fatty Liver Disease (NAFLD) varying from ben...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Pakistan Medical Association
2023-11-01
|
| Series: | Journal of the Pakistan Medical Association |
| Online Access: | https://www.ojs.jpma.org.pk/index.php/public_html/article/view/9769 |
| Summary: | Madam,
Non-alcoholic steatohepatitis (NASH), is described as having hepatic steatosis of >5%, inflammation, and hepatocyte damage (such as ballooning), including or excluding fibrosis¹. NASH falls under a group of liver diseases termed Non-alcoholic Fatty Liver Disease (NAFLD) varying from benign steatosis to inflammatory NASH and hepatic fibrosis.
---Continue
|
|---|---|
| ISSN: | 0030-9982 |